Suppr超能文献

牛磺鹅去氧胆酸抑制胃癌的增殖和侵袭并诱导其凋亡。

Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis.

作者信息

Zhang Dongwei, Zhu Yongfu, Su Ya, Yu Minghui, Xu Xiaozhou, Wang Chunhua, Zhang Shaohu, Xia Liming

机构信息

Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Department of Spleen and Stomach, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

出版信息

J Food Biochem. 2022 Mar;46(3):e13866. doi: 10.1111/jfbc.13866. Epub 2021 Jul 18.

Abstract

Taurochenodeoxycholic acid (TCDCA) is the principal ingredient of Compound Shougong Powder. Despite traditional Chinese medicine (TCM) research demonstrates that Compound Shougong Powder can restrict tumor growth, whether TCDCA exerts a role in suppressing cancer as the major ingredient of Compound Shougong Powder remains unknown. This study aims to clarify the regulatory mechanism of TCDCA on gastric cancer. Gastric cancer cells SGC-7901 were cultured to investigate the effects of TCDCA on proliferation and apoptosis. Furthermore, a subcutaneously implanted tumor model was established using SGC-7901 cells in BALB/C nude mice and tumor volume was measured under low and high dose treatment of TCDCA. Cell proliferation, apoptosis, and invasion were subjected to 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay, flow cytometry, and transwell assay. Differentially expressed genes were screened by transcriptome sequencing. Nude mouse tumorigenicity assay was initiated to identify the effect of TCDCA on both tumor volume and weight, and the expression of candidate genes screened by transcriptome sequencing was determined by real-time fluorescence quantification (qPCR) and Western blot. The experiments revealed that TCDCA could significantly inhibit the proliferation and invasion of gastric cancer cells and induce apoptosis of these cells. Meanwhile, test findings via in vivo indicated that TCDCA severely diminished the volume and weight of tumors. This study first demonstrated that TCDCA inhibited the proliferation and invasion of gastric cancer and induced apoptosis, which is expected to serve as an experimental basis for the application of TCM in tumor therapeutic options. PRACTICAL APPLICATIONS: Through this study, the inhibitory effect of Taurochenodeoxycholic acid on gastric cancer can be clarified, which provides a new research basis for the application of traditional Chinese medicine (TCM) and TCM monomer in cancer. In addition, this study can further promote the research and application of Chinese traditional medicine, which has important application value and economic benefits.

摘要

牛磺熊去氧胆酸(TCDCA)是复方守宫散的主要成分。尽管中医研究表明复方守宫散可抑制肿瘤生长,但TCDCA作为复方守宫散的主要成分是否在抑制癌症中发挥作用仍不清楚。本研究旨在阐明TCDCA对胃癌的调控机制。培养胃癌细胞SGC-7901以研究TCDCA对增殖和凋亡的影响。此外,使用SGC-7901细胞在BALB/C裸鼠中建立皮下植入肿瘤模型,并在TCDCA低剂量和高剂量治疗下测量肿瘤体积。通过3-(4,5)-二甲基噻唑-2,5-二苯基四氮唑溴盐(MTT)法、流式细胞术和Transwell法检测细胞增殖、凋亡和侵袭。通过转录组测序筛选差异表达基因。启动裸鼠致瘤性试验以确定TCDCA对肿瘤体积和重量的影响,并通过实时荧光定量(qPCR)和蛋白质免疫印迹法检测转录组测序筛选的候选基因的表达。实验表明,TCDCA可显著抑制胃癌细胞的增殖和侵袭并诱导这些细胞凋亡。同时,体内试验结果表明,TCDCA可显著减小肿瘤的体积和重量。本研究首次证明TCDCA抑制胃癌的增殖和侵袭并诱导凋亡,有望为中医在肿瘤治疗选择中的应用提供实验依据。实际应用:通过本研究,可以阐明牛磺熊去氧胆酸对胃癌的抑制作用,为中药及中药单体在癌症中的应用提供新的研究依据。此外,本研究可进一步推动中药的研究与应用,具有重要的应用价值和经济效益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验